Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
03 February 2020 | Story Cobus van Jaarsveld | Photo Charl Devenish
Traffic Circle on the UFS Bloemfontein Campus
The Department of Protection Services shares how to #BSafe at traffic circles.

For the majority of drivers, one of the most confusing driving laws is the correct use of a traffic circle, especially in Bloemfontein with the large number of smaller traffic circles constructed over the past few years; also across the University of the Free State (UFS) Bloemfontein Campus.

“In fact, many motorists do not know that there is a difference between a larger traffic circle and a mini traffic circle, other than their size. Can you really be frustrated if someone cuts you off at a traffic circle if you don't know the rules? Arrive Alive has shed some light on the issue,” said Cobus van Jaarsveld, Assistant Director: Threat Detection, Investigations and Liaison in the UFS Department of Protection Services.

What is the difference between the two circles?

A traffic circle is classified as large when it has a minimum diameter of about 16 metres and a 1,5 to 2 metre flattened kerb, which allows heavy vehicles to drive onto a small section of the circle. A mini traffic circle is normally not more than seven to ten metres in diameter and the entire circle is mountable for heavy vehicles.

Are there different rules for each?

Yes – the rule of thumb is that mini traffic circles, which are usually found in residential areas, have the same rules as a four-way stop – first come first served. For larger traffic circles, which are usually found at busy crossings to assist with the traffic flow, you must give way to the right.

Rules to remember at a large traffic circle

As you arrive at a large traffic circle, traffic coming from your right has right of way, regardless of how many cars there are. Wait until there is a gap in the traffic and then ease slowly into the circle. Watch out for other traffic in the circle and be aware that they may not be using their indicators.

Use your indicators

Signal when you are going to turn – switch your indicator on immediately after passing the exit prior to the one you intend taking. If you are taking the first exit, i.e. you're turning left, then flick on your left indicator and keep in the outside/left-hand lane. Keeping in the outside/left-hand lane also works well if you're continuing straight ahead, as your exit is very close. After you've passed the left-turn exit and yours is next, signal left and you're free. If you're turning right or performing a U-turn, keep in the inside/right-hand lane. Only signal left and change into the left-hand lane once you've passed the other exits and only yours is ahead.

Rules to remember at a mini traffic circle

The first vehicle to cross the line has the right of way, so it really works on the same principle as a four-way stop or yield sign. Proceed in a clockwise direction around the circle, without driving on it.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept